HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.

about

HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.

Item

http://www.wikidata.org/entity/Q38626421

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.

@en

type

Item

label

HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.

@en

prefLabel

HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.

@en

P1476

HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.

@en

P2093

Eva Koziolová

http://www.w3.org/2001/XMLSchema#string

Karel Ulbrich

http://www.w3.org/2001/XMLSchema#string

Petr Chytil

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin

Biodegradable Micellar HPMA-Based Polymer-Drug Conjugates with Betulinic Acid for Passive Tumor Targeting.

A deeper insight into the postpolymerization modification of polypenta fluorophenyl methacrylates to poly(n-(2-hydroxypropyl) methacrylamide).

Direct, controlled synthesis of the nonimmunogenic, hydrophilic polymer, poly(N-(2-hydroxypropyl)methacrylamide) via RAFT in aqueous media.

Synthesis and characterization of HE-24.8: a polymeric contrast agent for magnetic resonance angiography.

Modification of cyclosporin A and conjugation of its derivative to HPMA copolymers.

Functionalized semitelechelic poly[N-(2-hydroxypropyl)methacrylamide] for protein modification.

Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data.

HPMA copolymers: origins, early developments, present, and future.

Conformational consequences of cooperative binding of a coiled-coil peptide motif to poly(N-(2-hydroxypropyl) methacrylamide) HPMA copolymers.

P31

scholarly article

P356

10.1002/MABI.201700209

http://www.w3.org/2001/XMLSchema#string

P50

Karel Ulbrich

Tomáš Etrych

P577

2017-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28805040

http://www.w3.org/2001/XMLSchema#string